Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · IEX Real-Time Price · USD
4.040
+0.040 (1.00%)
At close: Mar 28, 2024, 4:00 PM
3.910
-0.130 (-3.22%)
After-hours: Mar 28, 2024, 6:49 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $339.60 million as of March 28, 2024. Its market cap has increased by 23.49% in one year.
Market Cap
339.60M
Enterprise Value
-236.10M
1-Year Change
23.49%
Ranking
Category
Stock Price
$4.04
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $339.60M, a decrease of -82.47%. That is a compound annual growth rate of -39.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 340.00M | 0.98% |
Mar 27, 2024 | 336.70M | 6.11% |
Mar 26, 2024 | 317.30M | -1.31% |
Mar 25, 2024 | 321.50M | -5.91% |
Mar 22, 2024 | 341.70M | -0.99% |
Mar 21, 2024 | 345.10M | 3.82% |
Mar 20, 2024 | 332.40M | 0.24% |
Mar 19, 2024 | 331.60M | -1.51% |
Mar 18, 2024 | 336.70M | -0.24% |
Mar 15, 2024 | 337.50M | 4.17% |
Mar 14, 2024 | 324.00M | -3.51% |
Mar 13, 2024 | 335.80M | -0.27% |
Mar 12, 2024 | 336.70M | -0.74% |
Mar 11, 2024 | 339.20M | 0.74% |
Mar 8, 2024 | 336.70M | -1.95% |
Mar 7, 2024 | 343.40M | 1.24% |
Mar 6, 2024 | 339.20M | 1.01% |
Mar 5, 2024 | 335.80M | -1.24% |
Mar 4, 2024 | 340.00M | -9.21% |
Mar 1, 2024 | 374.50M | 3.25% |
Feb 29, 2024 | 362.70M | -1.39% |
Feb 28, 2024 | 367.80M | -3.34% |
Feb 27, 2024 | 380.50M | 5.58% |
Feb 26, 2024 | 360.40M | 2.85% |
Feb 23, 2024 | 350.40M | 4.22% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bioventus | 325.77M |
Kamada | 325.74M |
Spok Holdings | 321.38M |
SOPHiA GENETICS | 321.28M |
Opthea | 318.15M |
Cerus | 314.65M |
Sanara MedTech | 313.79M |
Sera Prognostics | 308.04M |